CHRONIC MYELOGENOUS LEUKEMIA (CML)
Clinical trials for CHRONIC MYELOGENOUS LEUKEMIA (CML) explained in plain language.
Never miss a new study
Get alerted when new CHRONIC MYELOGENOUS LEUKEMIA (CML) trials appear
Sign up with your email to follow new studies for CHRONIC MYELOGENOUS LEUKEMIA (CML), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Cord blood transplants made available for thousands with blood cancers
Disease control Recruiting nowThis study gives people with blood cancers, immune disorders, and other serious diseases access to cord blood transplants that are not yet FDA-approved. It includes children and adults of any age. The main goal is to see how well the new blood cells grow after transplant.
Matched conditions: CHRONIC MYELOGENOUS LEUKEMIA (CML)
Sponsor: Center for International Blood and Marrow Transplant Research • Aim: Disease control
Last updated May 26, 2026 04:34 UTC
-
New cord blood transplant method aims to beat High-Risk blood cancers
Disease control Recruiting nowThis study tests an improved method for cord blood transplants in adults with hard-to-treat blood cancers like leukemia and lymphoma. The approach uses a standard set of steps—including chemotherapy, radiation, and careful follow-up—to help the body accept the new stem cells. Res…
Matched conditions: CHRONIC MYELOGENOUS LEUKEMIA (CML)
Phase: PHASE2 • Sponsor: Memorial Sloan Kettering Cancer Center • Aim: Disease control
Last updated May 26, 2026 04:33 UTC